Please login to the form below

Valid Insight Supporting Initiatives To Support COVID-19 Travel Bans

The World Pharma Pricing Market Access & Evidence Congress

We all have a role to take action against COVID-19. As a sponsor and exhibitor of the World Pharma Pricing, Market Access & Evidence Congress, Valid Insight fully support the organisers’ responsible decision to postpone this event. We won't be seeing you in Amsterdam this month, but we hope to see you in September 2020.

Learn more about the event here: https://www.validinsight.com/events-news/world-pharma-pricing-market-access-and-evidence-congress-2020/

4th March 2020

Share

Tags

Company Details

Valid Insight

+44 (0) 20 3750 9833

Contact Website

Address:
152-160 City Road
Kemp House
London
EC1V 2NX
United Kingdom

Latest content on this profile

Valid Insight Queen’s Award presentation: recognising a market access company
Take a look at the very moment that one of the most esteemed business awards, the Queen’s Award for Enterprise in International Trade 2019, was presented to our team.
Valid Insight
Speakers Announced: Maintaining Market Access Continuity through a Global Pandemic Webinar
The global outbreak of coronavirus (COVID-19) and subsequent perception of public health risk creates challenges for international business continuity and market access planning.
Valid Insight
Webinar: Maintaining Market Access Continuity through a Global Pandemic
The global outbreak of coronavirus (COVID-19) and subsequent perception of public health risk creates challenges for international business continuity and market access planning.
Valid Insight
Valid Insight Supporting Initiatives To Support COVID-19 Travel Bans
The World Pharma Pricing Market Access & Evidence Congress
Valid Insight
Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines.
Valid Insight
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the evaluation of health and healthcare interventions.
Valid Insight